TCM
Tamarack Capital Management Portfolio holdings
AUM
$503M
This Quarter Return
-5.61%
1 Year Return
+15.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$503M
AUM Growth
+$503M
(-15%)
Cap. Flow
-$29.2M
Cap. Flow
% of AUM
-5.82%
Top 10 Holdings %
Top 10 Hldgs %
74.29%
Holding
40
New
4
Increased
8
Reduced
10
Closed
9
Top Buys
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
$16M |
| 2 |
Medtronic
MDT
|
$13.4M |
| 3 |
Amgen
AMGN
|
$10.4M |
| 4 |
IMPR
IMPRIVATA, INC COM
IMPR
|
$7.11M |
| 5 |
CORI
Corium International, Inc.
CORI
|
$5.66M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$16.6M |
| 2 |
MiMedx Group
MDXG
|
$15.1M |
| 3 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$11.6M |
| 4 |
Bruker
BRKR
|
$10.2M |
| 5 |
ICU Medical
ICUI
|
$10.1M |
Sector Composition
| 1 | Healthcare | 85.08% |
| 2 | Technology | 5.04% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
1
DELISTED
Patterson Companies, Inc.
PDCO
| $53M | 6.31% | 1,225,000 +370,000 | +43% | +$16M |
|
|
ELGX
2
DELISTED
Endologix Inc
ELGX
| $49.7M | 5.91% | 4,050,000 | – | – |
|
|
3
Medtronic
MDT
$119B
| $46.9M | 5.58% | 700,000 +200,000 | +40% | +$13.4M |
|
4
Quest Diagnostics
DGX
$20.3B
| $43M | 5.12% | 700,000 | – | – |
|
5
Integer Holdings
ITGR
$3.78B
| $39.5M | 4.7% | 700,000 -23,962 | -3% | -$1.35M |
|
|
6
Becton Dickinson
BDX
$55.3B
| $36.5M | 4.34% | 275,000 -125,000 | -31% | -$16.6M |
|
|
NXTM
7
DELISTED
NxStage Medical Inc.
NXTM
| $31.5M | 3.75% | 2,000,000 +325,000 | +19% | +$5.13M |
|
|
MDRX
8
DELISTED
Veradigm Inc. Common Stock
MDRX
| $26.7M | 3.17% | 2,150,000 +375,000 | +21% | +$4.65M |
|
|
IMPR
9
DELISTED
IMPRIVATA, INC COM
IMPR
| $25.3M | 3.01% | 1,425,000 +400,000 | +39% | +$7.11M |
|
10
Alkermes
ALKS
$4.78B
| $21.4M | 2.55% | 365,000 -35,000 | -9% | -$2.05M |
|
11
AtriCure
ATRC
$1.84B
| $18.1M | 2.15% | 825,000 -60,000 | -7% | -$1.31M |
|
|
LMNX
12
DELISTED
Luminex Corp
LMNX
| $16.1M | 1.91% | 950,000 -50,000 | -5% | -$846K |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $14.8M | 1.76% | 110,000 -11,050 | -9% | -$1.48M |
|
|
CORI
14
DELISTED
Corium International, Inc.
CORI
| $12.4M | 1.47% | 1,325,000 +605,615 | +84% | +$5.66M |
|
|
SRGA
15
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $11.1M | 1.32% | 1,950,000 -50,000 | -3% | -$284K |
|
|
AMRN
16
Amarin Corp
AMRN
$311M
| $11M | 1.31% | 5,700,000 +2,475,310 | +77% | +$4.78M |
|
|
17
Amgen
AMGN
$155B
| $10.4M | 1.23% | +75,000 | New | +$10.4M |
|
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $9.26M | 1.1% | 785,000 -265,000 | -25% | -$3.12M |
|
19
Perrigo
PRGO
$3.27B
| $7.86M | 0.94% | 50,000 | – | – |
|
|
OXFD
20
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.06M | 0.6% | 375,000 -129,668 | -26% | -$1.75M |
|
21
Cerus
CERS
$251M
| $4.09M | 0.49% | 900,000 +34,830 | +4% | +$158K |
|
22
Lantheus
LNTH
$3.73B
| $2.65M | 0.31% | 615,000 -1,155,918 | -65% | -$4.97M |
|
|
STRM
23
DELISTED
Streamline Health Solutions
STRM
| $2.61M | 0.31% | 1,138,000 | – | – |
|
24
Heron Therapeutics
HRTX
$207M
| $1.83M | 0.22% | +75,000 | New | +$1.83M |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $1.21M | 0.14% | +25,000 | New | +$1.21M |
|